» Articles » PMID: 36072286

Model-based Intensification of CHO Cell Cultures: One-step Strategy from Fed-batch to Perfusion

Overview
Date 2022 Sep 8
PMID 36072286
Authors
Affiliations
Soon will be listed here.
Abstract

There is a growing interest in continuous processing of the biopharmaceutical industry. However, the technology transfer from traditional batch-based processes is considered a challenge as protocol and tools still remain to be established for their usage at the manufacturing scale. Here, we present a model-based approach to design optimized perfusion cultures of Chinese Hamster Ovary cells using only the knowledge captured during small-scale fed-batch experiments. The novelty of the proposed model lies in the simplicity of its structure. Thanks to the introduction of a new catch-all variable representing a bulk of by-products secreted by the cells during their cultivation, the model was able to successfully predict cellular behavior under different operating modes without changes in its formalism. To our knowledge, this is the first experimentally validated model capable, with a single set of parameters, to capture culture dynamic under different operating modes and at different scales.

Citing Articles

Time-Resolved Hierarchical Modeling Highlights Metabolites Influencing Productivity and Cell Death in Chinese Hamster Ovary Cells.

Eriksson A, Richelle A, Trygg J, Scholze S, Pijeaud S, Antti H Biotechnol J. 2025; 20(3):e202400624.

PMID: 40065671 PMC: 11894446. DOI: 10.1002/biot.202400624.


Hybrid modeling for in silico optimization of a dynamic perfusion cell culture process.

Agarwal P, McCready C, Ng S, Ng J, van de Laar J, Pennings M Biotechnol Prog. 2024; 41(1):e3503.

PMID: 39291457 PMC: 11831417. DOI: 10.1002/btpr.3503.

References
1.
Steinwandter V, Borchert D, Herwig C . Data science tools and applications on the way to Pharma 4.0. Drug Discov Today. 2019; 24(9):1795-1805. DOI: 10.1016/j.drudis.2019.06.005. View

2.
Wouters O, Mckee M, Luyten J . Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. JAMA. 2020; 323(9):844-853. PMC: 7054832. DOI: 10.1001/jama.2020.1166. View

3.
DiMasi J, Grabowski H, Hansen R . Innovation in the pharmaceutical industry: New estimates of R&D costs. J Health Econ. 2016; 47:20-33. DOI: 10.1016/j.jhealeco.2016.01.012. View

4.
Finelli L, Narasimhan V . Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development. Clin Pharmacol Ther. 2020; 108(4):756-761. PMC: 7540662. DOI: 10.1002/cpt.1850. View

5.
Ha T, Kim D, Kim C, Grav L, Lee G . Factors affecting the quality of therapeutic proteins in recombinant Chinese hamster ovary cell culture. Biotechnol Adv. 2021; 54:107831. DOI: 10.1016/j.biotechadv.2021.107831. View